Skip to content

The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05766787
Enrollment
190
Registered
2023-03-13
Start date
2023-03-29
Completion date
2023-06-02
Last updated
2024-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Ametropia

Keywords

Myopia

Brief summary

The purpose of this study is to assess the clinical performance of two reusable silicone hydrogel contact lenses when worn on a daily wear basis.

Detailed description

In this crossover study, subjects will wear each lens product for approximately 14 days and attend 7 scheduled visits. The expected overall duration of exposure to the study products is approximately 28 days.

Interventions

Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection

Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection

Hydrogen peroxide based contact lens cleaning and disinfecting solution

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Successful wear of spherical soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months. * Best Corrected Visual Acuity (BCVA) of 20/25 Snellen (0.10 logMAR) or better in each eye. * Willing to stop wearing habitual contact lenses for the duration of study participation. * Other protocol-specific inclusion criteria may apply.

Exclusion criteria

* Any eye infection, inflammation, abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator. * Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the investigator. * Habitual wear of AOHP contact lenses. * Habitual wear of any daily disposable contact lenses. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Least Squares Mean Distance VA With Study Lenses at Week 1Week 1 of each lens product worn during the corresponding crossover periodVisual acuity (VA) was assessed for each eye individually with study lenses in place using logarithmic of the Minimum Angle of Resolution (logMAR) reading charts. LogMAR values typically range from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 15 investigative sites located in the United States.

Pre-assignment details

Of the 190 enrolled, 3 participants were exited prior to randomization as screen failures. Of the 187 randomized, 1 participant was discontinued prior to exposure to the study lenses due to ocular pre-treatment adverse events. This reporting group includes all participants exposed to any study lenses (186).

Participants by arm

ArmCount
LID022821, Then AOHP
Serafilcon A contact lenses worn first, with senofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
94
AOHP, Then LID022821
Senofilcon A contact lenses worn first, with serafilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
92
Total186

Withdrawals & dropouts

PeriodReasonFG000FG001
First Wear Period, Approximately 7 DaysAdverse Event01
First Wear Period, Approximately 7 DaysWithdrawal by Subject12
Second Wear Period, Approximately 7 DaysAdverse Event01

Baseline characteristics

CharacteristicLID022821, Then AOHPAOHP, Then LID022821Total
Age, Continuous34.1 years
STANDARD_DEVIATION 8.6
33.9 years
STANDARD_DEVIATION 9
34.0 years
STANDARD_DEVIATION 8.8
Race/Ethnicity, Customized
American Indian or Alaska Native
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Asian
20 Participants19 Participants39 Participants
Race/Ethnicity, Customized
Black or African American
7 Participants9 Participants16 Participants
Race/Ethnicity, Customized
Hispanic or Latino
6 Participants7 Participants13 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
88 Participants85 Participants173 Participants
Race/Ethnicity, Customized
Other
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
White
66 Participants62 Participants128 Participants
Sex: Female, Male
Female
60 Participants64 Participants124 Participants
Sex: Female, Male
Male
34 Participants28 Participants62 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 1860 / 3640 / 1820 / 3700 / 185
other
Total, other adverse events
0 / 1860 / 3640 / 1820 / 3700 / 185
serious
Total, serious adverse events
0 / 1860 / 3640 / 1820 / 3700 / 185

Outcome results

Primary

Least Squares Mean Distance VA With Study Lenses at Week 1

Visual acuity (VA) was assessed for each eye individually with study lenses in place using logarithmic of the Minimum Angle of Resolution (logMAR) reading charts. LogMAR values typically range from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.

Time frame: Week 1 of each lens product worn during the corresponding crossover period

Population: Full Analysis Set: All randomized subjects who were exposed to any study lenses evaluated in this study with data at Week 1 visit.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
LID022821Least Squares Mean Distance VA With Study Lenses at Week 1-0.11 logMARStandard Error 0.005
AOHPLeast Squares Mean Distance VA With Study Lenses at Week 1-0.10 logMARStandard Error 0.005

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026